Intraprostatic inflammation is positively associated with serum PSA in men with PSA <4 ng ml(-1), normal DRE and negative for prostate cancer

Biopsies performed for elevated serum PSA often show inflammatory infiltrates. However, the influence of intraprostatic inflammation on serum PSA in men without biopsy indication and negative for prostate cancer has not been described in detail. We studied 224 men in the placebo arm of the Prostate...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Prostate cancer and prostatic diseases 2015-09, Vol.18 (3), p.264-269
Hauptverfasser: Umbehr, M H, Gurel, B, Murtola, T J, Sutcliffe, S, Peskoe, S B, Tangen, C M, Goodman, P J, Thompson, I M, Lippman, S M, Lucia, M S, Parnes, H L, Drake, C G, Nelson, W G, De Marzo, A M, Platz, E A
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 269
container_issue 3
container_start_page 264
container_title Prostate cancer and prostatic diseases
container_volume 18
creator Umbehr, M H
Gurel, B
Murtola, T J
Sutcliffe, S
Peskoe, S B
Tangen, C M
Goodman, P J
Thompson, I M
Lippman, S M
Lucia, M S
Parnes, H L
Drake, C G
Nelson, W G
De Marzo, A M
Platz, E A
description Biopsies performed for elevated serum PSA often show inflammatory infiltrates. However, the influence of intraprostatic inflammation on serum PSA in men without biopsy indication and negative for prostate cancer has not been described in detail. We studied 224 men in the placebo arm of the Prostate Cancer Prevention Trial (PCPT) who underwent end-of-study biopsy per trial protocol, had PSA 0 to ≤0.8, >0.8 to ≤1.5 and >1.5 to
doi_str_mv 10.1038/pcan.2015.19
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4537352</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1704345320</sourcerecordid><originalsourceid>FETCH-LOGICAL-p1112-788552a1f019f2ab4b3764be60f672fd0717f9254aeeef0606396400be64711e3</originalsourceid><addsrcrecordid>eNpVUUtrFEEQbkTJy9w8Sx8jZNaufu5AEEISNRBQNDkPvbPVmw7T3WP3bCS3XD36F_0l9pJV9FLPr76PqiLkFbAZMDF_O_Y2zjgDNYP2GdkDaXSjNJs_r7HQqjFzxXfJfil3jLEWWrZDdrlqRatA75Gfl3HKdsypTHbyPfXRDTaEGqdIfaFjKn7y9zg8UFtK6r2dcEm_--mWFszrQD9_Pa1DNGB8qm7yE_nr8UdcVROGowbeHNOYcrADPf9yQW1c0ogru2GlLmW6FUdaF-kxvyQvnB0KHm79Abl5f3F99rG5-vTh8uz0qhkBgNe15kpxC45B67hdyIUwWi5QM6cNd0tmwLiWK2kR0THNtGi1ZKwipAFAcUDePfGO60XAZY-bQwzdmH2w-aFL1nf_d6K_7VbpvpNKGKF4JTjaEuT0bY1l6oIvPQ6DjZjWpQPDpKhgzir09b9af0X-_EH8BqqijRY</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1704345320</pqid></control><display><type>article</type><title>Intraprostatic inflammation is positively associated with serum PSA in men with PSA &lt;4 ng ml(-1), normal DRE and negative for prostate cancer</title><source>MEDLINE</source><source>Springer Nature - Complete Springer Journals</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><creator>Umbehr, M H ; Gurel, B ; Murtola, T J ; Sutcliffe, S ; Peskoe, S B ; Tangen, C M ; Goodman, P J ; Thompson, I M ; Lippman, S M ; Lucia, M S ; Parnes, H L ; Drake, C G ; Nelson, W G ; De Marzo, A M ; Platz, E A</creator><creatorcontrib>Umbehr, M H ; Gurel, B ; Murtola, T J ; Sutcliffe, S ; Peskoe, S B ; Tangen, C M ; Goodman, P J ; Thompson, I M ; Lippman, S M ; Lucia, M S ; Parnes, H L ; Drake, C G ; Nelson, W G ; De Marzo, A M ; Platz, E A</creatorcontrib><description>Biopsies performed for elevated serum PSA often show inflammatory infiltrates. However, the influence of intraprostatic inflammation on serum PSA in men without biopsy indication and negative for prostate cancer has not been described in detail. We studied 224 men in the placebo arm of the Prostate Cancer Prevention Trial (PCPT) who underwent end-of-study biopsy per trial protocol, had PSA &lt;4 ng ml(-1), normal digital rectal examination and a biopsy negative for cancer. We analyzed data from hematoxylin and eosin-stained slides containing a mean of three biopsy cores. Inflammation measures included the extent (percentage of tissue area with inflammation) and intensity (product of scores for extent and grade) of total, acute and chronic inflammation in the entire tissue area examined, and by tissue compartment. We calculated median measures of inflammation by prebiopsy serum PSA tertile (&gt;0 to ≤0.8, &gt;0.8 to ≤1.5 and &gt;1.5 to &lt;4.0 ng ml(-1)). We estimated the association between percentage of tissue area with inflammation and natural logarithm of PSA using linear regression adjusting for age at biopsy. Median percentage of tissue area with inflammation increased from 2 to 5 to 9.5% across PSA tertiles (P-trend &lt;0.0001). For every 5% increase in tissue area with inflammation, log PSA increased by 0.061 ng ml(-1) (P=0.0002). Median extent and intensity scores increased across PSA tertiles in luminal and intraepithelial compartments for acute inflammation and in stromal and intraepithelial compartments for chronic inflammation (all P-trend ≤0.05). In men without clinical suspicion of prostate cancer, greater overall inflammation, luminal and intraepithelial acute inflammation and stromal and intraepithelial chronic inflammation were associated with higher serum PSA.</description><identifier>ISSN: 1365-7852</identifier><identifier>EISSN: 1476-5608</identifier><identifier>DOI: 10.1038/pcan.2015.19</identifier><identifier>PMID: 25939516</identifier><language>eng</language><publisher>England</publisher><subject>Aged ; Aged, 80 and over ; Biopsy ; Case-Control Studies ; Cross-Sectional Studies ; Humans ; Inflammation - pathology ; Male ; Middle Aged ; Prostate - pathology ; Prostate-Specific Antigen - blood ; Prostatic Neoplasms - blood ; Prostatic Neoplasms - pathology ; Risk Factors</subject><ispartof>Prostate cancer and prostatic diseases, 2015-09, Vol.18 (3), p.264-269</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,314,776,780,881,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/25939516$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Umbehr, M H</creatorcontrib><creatorcontrib>Gurel, B</creatorcontrib><creatorcontrib>Murtola, T J</creatorcontrib><creatorcontrib>Sutcliffe, S</creatorcontrib><creatorcontrib>Peskoe, S B</creatorcontrib><creatorcontrib>Tangen, C M</creatorcontrib><creatorcontrib>Goodman, P J</creatorcontrib><creatorcontrib>Thompson, I M</creatorcontrib><creatorcontrib>Lippman, S M</creatorcontrib><creatorcontrib>Lucia, M S</creatorcontrib><creatorcontrib>Parnes, H L</creatorcontrib><creatorcontrib>Drake, C G</creatorcontrib><creatorcontrib>Nelson, W G</creatorcontrib><creatorcontrib>De Marzo, A M</creatorcontrib><creatorcontrib>Platz, E A</creatorcontrib><title>Intraprostatic inflammation is positively associated with serum PSA in men with PSA &lt;4 ng ml(-1), normal DRE and negative for prostate cancer</title><title>Prostate cancer and prostatic diseases</title><addtitle>Prostate Cancer Prostatic Dis</addtitle><description>Biopsies performed for elevated serum PSA often show inflammatory infiltrates. However, the influence of intraprostatic inflammation on serum PSA in men without biopsy indication and negative for prostate cancer has not been described in detail. We studied 224 men in the placebo arm of the Prostate Cancer Prevention Trial (PCPT) who underwent end-of-study biopsy per trial protocol, had PSA &lt;4 ng ml(-1), normal digital rectal examination and a biopsy negative for cancer. We analyzed data from hematoxylin and eosin-stained slides containing a mean of three biopsy cores. Inflammation measures included the extent (percentage of tissue area with inflammation) and intensity (product of scores for extent and grade) of total, acute and chronic inflammation in the entire tissue area examined, and by tissue compartment. We calculated median measures of inflammation by prebiopsy serum PSA tertile (&gt;0 to ≤0.8, &gt;0.8 to ≤1.5 and &gt;1.5 to &lt;4.0 ng ml(-1)). We estimated the association between percentage of tissue area with inflammation and natural logarithm of PSA using linear regression adjusting for age at biopsy. Median percentage of tissue area with inflammation increased from 2 to 5 to 9.5% across PSA tertiles (P-trend &lt;0.0001). For every 5% increase in tissue area with inflammation, log PSA increased by 0.061 ng ml(-1) (P=0.0002). Median extent and intensity scores increased across PSA tertiles in luminal and intraepithelial compartments for acute inflammation and in stromal and intraepithelial compartments for chronic inflammation (all P-trend ≤0.05). In men without clinical suspicion of prostate cancer, greater overall inflammation, luminal and intraepithelial acute inflammation and stromal and intraepithelial chronic inflammation were associated with higher serum PSA.</description><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>Biopsy</subject><subject>Case-Control Studies</subject><subject>Cross-Sectional Studies</subject><subject>Humans</subject><subject>Inflammation - pathology</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Prostate - pathology</subject><subject>Prostate-Specific Antigen - blood</subject><subject>Prostatic Neoplasms - blood</subject><subject>Prostatic Neoplasms - pathology</subject><subject>Risk Factors</subject><issn>1365-7852</issn><issn>1476-5608</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2015</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpVUUtrFEEQbkTJy9w8Sx8jZNaufu5AEEISNRBQNDkPvbPVmw7T3WP3bCS3XD36F_0l9pJV9FLPr76PqiLkFbAZMDF_O_Y2zjgDNYP2GdkDaXSjNJs_r7HQqjFzxXfJfil3jLEWWrZDdrlqRatA75Gfl3HKdsypTHbyPfXRDTaEGqdIfaFjKn7y9zg8UFtK6r2dcEm_--mWFszrQD9_Pa1DNGB8qm7yE_nr8UdcVROGowbeHNOYcrADPf9yQW1c0ogru2GlLmW6FUdaF-kxvyQvnB0KHm79Abl5f3F99rG5-vTh8uz0qhkBgNe15kpxC45B67hdyIUwWi5QM6cNd0tmwLiWK2kR0THNtGi1ZKwipAFAcUDePfGO60XAZY-bQwzdmH2w-aFL1nf_d6K_7VbpvpNKGKF4JTjaEuT0bY1l6oIvPQ6DjZjWpQPDpKhgzir09b9af0X-_EH8BqqijRY</recordid><startdate>201509</startdate><enddate>201509</enddate><creator>Umbehr, M H</creator><creator>Gurel, B</creator><creator>Murtola, T J</creator><creator>Sutcliffe, S</creator><creator>Peskoe, S B</creator><creator>Tangen, C M</creator><creator>Goodman, P J</creator><creator>Thompson, I M</creator><creator>Lippman, S M</creator><creator>Lucia, M S</creator><creator>Parnes, H L</creator><creator>Drake, C G</creator><creator>Nelson, W G</creator><creator>De Marzo, A M</creator><creator>Platz, E A</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>201509</creationdate><title>Intraprostatic inflammation is positively associated with serum PSA in men with PSA &lt;4 ng ml(-1), normal DRE and negative for prostate cancer</title><author>Umbehr, M H ; Gurel, B ; Murtola, T J ; Sutcliffe, S ; Peskoe, S B ; Tangen, C M ; Goodman, P J ; Thompson, I M ; Lippman, S M ; Lucia, M S ; Parnes, H L ; Drake, C G ; Nelson, W G ; De Marzo, A M ; Platz, E A</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-p1112-788552a1f019f2ab4b3764be60f672fd0717f9254aeeef0606396400be64711e3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2015</creationdate><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>Biopsy</topic><topic>Case-Control Studies</topic><topic>Cross-Sectional Studies</topic><topic>Humans</topic><topic>Inflammation - pathology</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Prostate - pathology</topic><topic>Prostate-Specific Antigen - blood</topic><topic>Prostatic Neoplasms - blood</topic><topic>Prostatic Neoplasms - pathology</topic><topic>Risk Factors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Umbehr, M H</creatorcontrib><creatorcontrib>Gurel, B</creatorcontrib><creatorcontrib>Murtola, T J</creatorcontrib><creatorcontrib>Sutcliffe, S</creatorcontrib><creatorcontrib>Peskoe, S B</creatorcontrib><creatorcontrib>Tangen, C M</creatorcontrib><creatorcontrib>Goodman, P J</creatorcontrib><creatorcontrib>Thompson, I M</creatorcontrib><creatorcontrib>Lippman, S M</creatorcontrib><creatorcontrib>Lucia, M S</creatorcontrib><creatorcontrib>Parnes, H L</creatorcontrib><creatorcontrib>Drake, C G</creatorcontrib><creatorcontrib>Nelson, W G</creatorcontrib><creatorcontrib>De Marzo, A M</creatorcontrib><creatorcontrib>Platz, E A</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Prostate cancer and prostatic diseases</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Umbehr, M H</au><au>Gurel, B</au><au>Murtola, T J</au><au>Sutcliffe, S</au><au>Peskoe, S B</au><au>Tangen, C M</au><au>Goodman, P J</au><au>Thompson, I M</au><au>Lippman, S M</au><au>Lucia, M S</au><au>Parnes, H L</au><au>Drake, C G</au><au>Nelson, W G</au><au>De Marzo, A M</au><au>Platz, E A</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Intraprostatic inflammation is positively associated with serum PSA in men with PSA &lt;4 ng ml(-1), normal DRE and negative for prostate cancer</atitle><jtitle>Prostate cancer and prostatic diseases</jtitle><addtitle>Prostate Cancer Prostatic Dis</addtitle><date>2015-09</date><risdate>2015</risdate><volume>18</volume><issue>3</issue><spage>264</spage><epage>269</epage><pages>264-269</pages><issn>1365-7852</issn><eissn>1476-5608</eissn><abstract>Biopsies performed for elevated serum PSA often show inflammatory infiltrates. However, the influence of intraprostatic inflammation on serum PSA in men without biopsy indication and negative for prostate cancer has not been described in detail. We studied 224 men in the placebo arm of the Prostate Cancer Prevention Trial (PCPT) who underwent end-of-study biopsy per trial protocol, had PSA &lt;4 ng ml(-1), normal digital rectal examination and a biopsy negative for cancer. We analyzed data from hematoxylin and eosin-stained slides containing a mean of three biopsy cores. Inflammation measures included the extent (percentage of tissue area with inflammation) and intensity (product of scores for extent and grade) of total, acute and chronic inflammation in the entire tissue area examined, and by tissue compartment. We calculated median measures of inflammation by prebiopsy serum PSA tertile (&gt;0 to ≤0.8, &gt;0.8 to ≤1.5 and &gt;1.5 to &lt;4.0 ng ml(-1)). We estimated the association between percentage of tissue area with inflammation and natural logarithm of PSA using linear regression adjusting for age at biopsy. Median percentage of tissue area with inflammation increased from 2 to 5 to 9.5% across PSA tertiles (P-trend &lt;0.0001). For every 5% increase in tissue area with inflammation, log PSA increased by 0.061 ng ml(-1) (P=0.0002). Median extent and intensity scores increased across PSA tertiles in luminal and intraepithelial compartments for acute inflammation and in stromal and intraepithelial compartments for chronic inflammation (all P-trend ≤0.05). In men without clinical suspicion of prostate cancer, greater overall inflammation, luminal and intraepithelial acute inflammation and stromal and intraepithelial chronic inflammation were associated with higher serum PSA.</abstract><cop>England</cop><pmid>25939516</pmid><doi>10.1038/pcan.2015.19</doi><tpages>6</tpages></addata></record>
fulltext fulltext
identifier ISSN: 1365-7852
ispartof Prostate cancer and prostatic diseases, 2015-09, Vol.18 (3), p.264-269
issn 1365-7852
1476-5608
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4537352
source MEDLINE; Springer Nature - Complete Springer Journals; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals
subjects Aged
Aged, 80 and over
Biopsy
Case-Control Studies
Cross-Sectional Studies
Humans
Inflammation - pathology
Male
Middle Aged
Prostate - pathology
Prostate-Specific Antigen - blood
Prostatic Neoplasms - blood
Prostatic Neoplasms - pathology
Risk Factors
title Intraprostatic inflammation is positively associated with serum PSA in men with PSA <4 ng ml(-1), normal DRE and negative for prostate cancer
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-18T20%3A57%3A39IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Intraprostatic%20inflammation%20is%20positively%20associated%20with%20serum%20PSA%20in%20men%20with%20PSA%20%3C4%E2%80%89ng%E2%80%89ml(-1),%20normal%20DRE%20and%20negative%20for%20prostate%20cancer&rft.jtitle=Prostate%20cancer%20and%20prostatic%20diseases&rft.au=Umbehr,%20M%20H&rft.date=2015-09&rft.volume=18&rft.issue=3&rft.spage=264&rft.epage=269&rft.pages=264-269&rft.issn=1365-7852&rft.eissn=1476-5608&rft_id=info:doi/10.1038/pcan.2015.19&rft_dat=%3Cproquest_pubme%3E1704345320%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1704345320&rft_id=info:pmid/25939516&rfr_iscdi=true